P

Precision Biosensor Inc
KOSDAQ:335810

Watchlist Manager
Precision Biosensor Inc
KOSDAQ:335810
Watchlist
Price: 2 685 KRW 0.75% Market Closed
Market Cap: 48.2B KRW

Operating Margin

-23.5%
Current
Improving
by 3.8%
vs 3-y average of -27.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-23.5%
=
Operating Income
₩-4.6B
/
Revenue
₩19.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-23.5%
=
Operating Income
₩-4.6B
/
Revenue
₩19.7B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Precision Biosensor Inc
KOSDAQ:335810
47.9B KRW
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.5B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.7B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.4B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.4B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.8B CNY
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
771.3B JPY
Loading...
No Stocks Found

Market Distribution

Lower than 87% of companies in Korea
Percentile
13th
Based on 2 615 companies
13th percentile
-23.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Precision Biosensor Inc
Glance View

Market Cap
48.2B KRW
Industry
Health Care

Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.

Precision Biosensor Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-23.5%
=
Operating Income
₩-4.6B
/
Revenue
₩19.7B
What is Precision Biosensor Inc's current Operating Margin?

The current Operating Margin for Precision Biosensor Inc is -23.5%, which is above its 3-year median of -27.3%.

How has Operating Margin changed over time?

Over the last 3 years, Precision Biosensor Inc’s Operating Margin has decreased from -15.9% to -23.5%. During this period, it reached a low of -39.2% on Jun 30, 2024 and a high of -15.9% on Aug 30, 2022.

Back to Top